These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7308241)

  • 1. Comparative blood level of dihydroergotoxine (DHET) after administration of two oral forms (solution & tablet): a preliminary study.
    Aliache JM; Briot M; Couquelet J; Vigo P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):221-4. PubMed ID: 7308241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations.
    Woodcock BG; Habedank WD; Loh W; Herrmann W; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):660-3. PubMed ID: 3436686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulation.
    Setnikar I; Schmid K; Rovati LC; Vens-Cappell B; Mazur D; Kozak I
    Arzneimittelforschung; 2001 Jan; 51(1):2-6. PubMed ID: 11215321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the bioavailability of Redergin tablets (1.0 mg) and Redergin solution.
    Kopitar Z; Milovac J; Vrhovac B; Tadjer I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):134-8. PubMed ID: 7068286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotoxine kinetics in healthy men after intravenous and oral administration.
    Woodcock BG; Loh W; Habedank WD; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):622-7. PubMed ID: 7128002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioavailability of alpha-acetyldigoxin from Card-Hydergin--a fixed combination of Hydergine and acetyldigoxin.
    Klotz U
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):116-8. PubMed ID: 649228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of ergoloid mesylates liquid capsule.
    Schran HF
    Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.
    Sörgel F; Abisch E; Dennler HJ; Lang E
    Eur J Clin Pharmacol; 1984; 26(1):133-5. PubMed ID: 6714287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacolinetic and pharmacodynamic data analysis of theophylline for three different drug forms.
    Richter O; Reinhardt D; Appel R
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):479-89. PubMed ID: 6271690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
    Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
    Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers.
    Hollmann M; Müller-Peltzer H; Greger G; Brode E; Perucca E; Grimaldi R; Crema A
    Pharmacopsychiatry; 1987 Mar; 20(2):72-7. PubMed ID: 3588663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of clobazam after three oral dosage forms in health subjects.
    Vallner JJ; Needham TE; Jun HW; Brown WJ; Stewart JT; Kotzan JA; Honigberg IL
    J Clin Pharmacol; 1978 Jul; 18(7):319-24. PubMed ID: 27537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.